Dual Kinase Inhibition of EGFR/HER2: Design, Synthesis and Molecular Docking of Thiazolylpyrazolyl‐Based Aminoquinoline Derivatives as Anticancer Agents**-Reference-Cited by-同舟云学术

Dual Kinase Inhibition of EGFR/HER2: Design, Synthesis and Molecular Docking of Thiazolylpyrazolyl‐Based Aminoquinoline Derivatives as Anticancer Agents**

Published:2021-10-25 Issue:40 Volume:6 Page:11012-11021
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Batran Rasha Z.¹,El‐Kashak Walaa A.¹,El‐Daly Sherien M.²³,Ahmed Eman Y.¹^ORCID

Affiliation:

1. Chemistry of Natural Compounds Department Pharmaceutical and Drug Industries Research Division National Research Centre Dokki Cairo Egypt

2. Medical Biochemistry Department Medical Research Division National Research Centre Cairo Egypt

3. Cancer Biology and Genetics Laboratory Centre of Excellence for Advanced Sciences National Research Centre Cairo Egypt

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.202102917

Reference35 articles.

1. The Hallmarks of Cancer

2. The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma

3. The type 1 (EGFR-related) family of growth factor receptors and their ligands

4. SnapShot: EGFR Signaling Pathway

5. Cell Signaling by Receptor Tyrosine Kinases

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and molecular modeling of pyrazoline based coumarin derivatives as tubulin polymerization inhibitors;Journal of Molecular Structure;2024-12

2. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10

3. Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy;Journal of Molecular Structure;2024-08

4. Naturally based pyrazoline derivatives as aminopeptidase N, VEGFR2 and MMP9 inhibitors: design, synthesis and molecular modeling;RSC Advances;2024

5. Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review;International Journal of Biological Macromolecules;2023-12